This study provides valuable insights into the immunological profiles of HIV-1 infected individuals under different treatment regimens, particularly the effects of HAART on cytokine levels. The findings could inform the development of novel therapeutic strategies aimed at modulating immune responses in HIV patients. Given the ongoing global demand for effective HIV treatments, this research may enhance competitive positioning for companies developing immunomodulatory therapies. Additionally, the study's completion suggests that the data could be leveraged for further research or partnerships, particularly in the context of combination therapies targeting immune modulation.